Selective Serotonin Re-uptake Inhibitors (SSRIs) for preventing migraine and tension-type headaches

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Moja, Lorenzo ^a   Cusi, Cristina ^b   Sterzi, Roberto ^c   Canepari, Claudio ^d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SANT ANNA HOSPITAL   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Humans; Migraine disorders *drug therapy ; Randomized controlled trials as topic; Serotonin uptake inhibitors *therapeutic use ; Tension type headache *drug therapy

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; MIANSERIN; PAROXETINE; PLACEBO; SERTRALINE; SULPIRIDE;

ANOREXIA; ANXIETY; ASTHENIA; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXCITEMENT; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; INSOMNIA; MIGRAINE; MOOD CHANGE; NAUSEA; OUTCOME ASSESSMENT; PROPHYLAXIS; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SIDE EFFECT; SYSTEMATIC REVIEW; TENSION HEADACHE; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WEAKNESS; XEROSTOMIA;

EID: 77950114287     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002919.pub2     Document Type: Review

References (83)

1. Adly 1992 {published data only} Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache 1992;32(2):101-4.
2. Bank 1994 {published data only} Bank J. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache 1994;34(8):476-8.
3. Bendtsen 1996 {published data only} Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. Journal of Neurology, Neurosurgery & Psychiatry 1996;61(3):285-90.
4. Boz 2003 {published data only} Boz C, Altunayoglu V, Velioglu S, Ozmenoglu M. Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patients. Journal of Headache and Pain 2003; 4(2):72-78.
5. C. d'Amato 1999a {published data only} Colucci d'Amato C, Pizza V, Marmolo T, Giordano E, Alfano V, Nasta A. Fluoxetine for migraine prophylaxis: a double-blind trial. Headache 1999;39(10):716-9.
6. Krymchantowski 2002 {published data only} Krymchantowski AV, Silva MT, Barbosa JS, Alves LA. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache 2002;42(6):510-4.
7. Landy 1999 {published data only} Landy S, McGinnis J, Curlin D, Laizure SC. Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache 1999;39 (1):28-32.
8. Langemark 1993 {published data only} Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 1994;34(1):20-4.
9. Manna 1994 {published data only} Manna V, Bolino F, Di Cicco L. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. Headache 1994;34(1):44-9.
10. Oguzhanoglu 1999 {published data only} Oguzhanoglu A, Sahiner T, Kurt T, Akalin O. Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches. Cephalalgia 1999;19(5): 531-2.
11. Polisca 1992 {published data only} Polisca R, Signoretti P, Marchi P. Fluoxetine in the treatment of migraine with interval headache [La fluoxetina nella terapia della emicrania con cefalea intervallare]. Rassegna Internazionale di Clinica e Terapia 1992;72(9):408-15.
12. Steiner 1998 {published data only} Steiner TJ, Ahmed F, Findley LJ, MacGregor EA, Wilkinson M. S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. Cephalalgia 1998;18(5): 283-6.
13. Walker 1997 {published data only} Walker Z, Walker RWH, Robertson MM, Stansfeld S. Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache 1998; 38(7):523-8.
14. Andersson 1981 {published data only} Andersson PG, Petersen EN. Propranolol and femoxetine, a 5-HTuptake inhibitor, in migraine prophylaxis. A double-blind crossover study. Acta Neurologica Scandinavica 1981;64(4):280-8.
15. Ansari 2000 {published data only} Ansari A. The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature. Harvard Review of Psychiatry 2000;7(5):257-77.
16. Becker 1999 {published data only} Becker WJ. Evidence based migraine prophylactic drug therapy. Canadian Journal of Neurological Sciences 1999;26 Suppl 3: S27-S32.
17. Bittman 1992 {published data only} Bittman B, Emanuele S. Fluoxetine: side effects and efficacy in a headache population. Headache Quarterly 1992;3(1):82-5.
18. Black 1995 {published data only} Black KJ, Sheline YI. Paroxetine as migraine prophylaxis. Journal of Clinical Psychiatry 1995;56(7):330-1.
19. Bonazzi 1991 {published data only} Bonazzi A, Giagnorio F. Fluoxetine vs. amitriptyline in the prophylaxis of tension type headache. Cephalalgia 1991;11 Suppl 11:341-2.
20. Bussone 1991 {published data only} Bussone G, Sandrini G, Patruno G, Ruiz L, Tassorelli C, Nappi G. Effectiveness of fluoxetine on pain and depression in chronic headache disorders. In: Nappi G, Bono G, Sandrini G, Martignoni E, Micieli G editor(s). Headache and depression: serotonin pathways as a common clue. New York: Raven Press, 1991:265-72.
21. C. d'Amato 1998 {published data only} Colucci d'Amato C, Pizza V, Marmolo T, Giordano E, Alfano V. Paroxetine versus flunarizine in the preventive treatment of migraine. Headache Quarterly 1998;9(3): 266-7.
22. C. d'Amato 1999b {published data only} Colucci d'Amato C, Pizza V, Marmolo T, Giordano E, Alfano V, Ruggiero A, et al.Experience of treatment with SSRI in migraine prophylaxis [Esperienza del trattamento con SSRI nella profilassi dell'emicrania]. Atti del 14° congresso Nazionale della Societa' Italiana per lo studio delle cefalee; 1999 sett 19-22; Perugia. CITY OF PUBLICATION: PUBLISHER OF CONFERENCE PROCEEDINGS, 1999:79.
23. C.d'Amato 2000 {published data only} Colucci d'Amato C, Pizza V, Marmolo T, Giordano E, Alfano V, Ruggiero A. Migraine prophylactic therapy: citalopram versus flunarizine. Headache Quarterly 2000;11(3):213-5.
24. D'Amico 1998 {published data only} D'Amico D, Grazzi L, Leone M, Moschiano F, Bussone G. A review of the treatment of primary headaches. Part II: tension-type headache. Italian Journal of Neurological Sciences 1998;19(1):2-9.
25. Delle Chiaie 1994 {published data only} Delle Chiaie R, Talamonti F, Regine F. Physiopathology and nosography of somatoform pain syndromes: rationale and efficacy of fluoxetine drug treatment [Fisiopatologia e nosografia delle sindromi dolorose somatoformi. Razionale d'impiego ed efficacia della fluoxetina]. Medicina-Psicosomatica 1994;39(2): 143-7.
26. Diamond 1989 {published data only} Diamond S, Freitag FG. The use of fluoxetine in the treatment of headache. Clinical Journal of Pain 1989;5(2):200-1.
27. Foster 1994 {published data only} Foster CA, Bafaloukos J. Paroxetine in the treatment of chronic daily headache. Headache 1994;34(10):587-9.
28. Hays 1997 {published data only} Hays P. Paroxetine prevents migraines. Journal of Clinical Psychiatry 1997;58(1):30- 1.
29. Iannacchero 1999 {published data only} Iannacchero R, Ambrosio A, De Rose F, Flippo A, Ambrosio LA. Efficacy and tolerability of Citalopram in chronic headache syndrome prophylaxis [Efficacia e tollerabilita'del Citaloprom nella profilassi delle sindromi cefalalgiche cronicizzate: comorbilita' emicrania senz'aura e depressione]. Psichiatria 1999;VOLUME NUMBER(ISSUE NUMBER):73-7.
30. Joffe 1997 {published data only} Joffe RT, Sokolov ST. Co-administration of fluoxetine and sumatriptan: the Canadian experience. Acta Psychiatrica Scandinavica 1997;95(6):551-2.
31. Jung 1997 {published data only} Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. Journal of General Internal Medicine 1997;12(6):384-9.
32. Kangasniemi 1983 {published data only} Kangasniemi PJ, Nyrke T, Lang AH, Petersen E. Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine. Acta Neurologica Scandinavica 1983;68(4): 262-7.
33. Karageorgiou 1996 {published data only} Karageorgiou CE, Spantideas A, Triantopoulou M, Lekkou G, Robotis A, Papatriantaphylou J. A pilot study of paroxetin a serotonin reuptake inhibitor and amitriptyline in the treatment of chronic tension type headache. Functional Neurology 1996;11(2-3): 157.
34. Kathpal 1998 {published data only} Kathpal GS. Role of SSRIs in the management of migraine. Headache Quarterly 1998;9(3):265-6.
35. Lampl 1995 {published data only} Lampl C, Klingler D. Chronic and episodic tension-type headache: prophylactic therapy with citalopram. Neuropsychiatrie 1995;9(1): 15-9.
36. Massiou 2000 {published data only} Massiou H. Prophylactic treatments of migraine [Les traitements prophylactiques de la migraine]. Revue Neurologique 2000;156 Suppl 4:4S79-86.
37. Orholm 1986 {published data only} Orholm M, Honorè PF, Zeeberg I. A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine. Acta Neurologica Scandinavica 1986;74(3): 235-9.
38. Ramadan 1997 {published data only} Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 1997;17(2): 73-80.
39. Redillas 2000 {published data only} Redillas C, Solomon S. Prophylactic pharmacological treatment of chronic daily headache. Headache 2000;40(2):83-102.
40. Sandrini 1991 {published data only} Sandrini G, Ruiz L, Patruno G, Bussone G, Verri AP, Nappi G. Antalgic and antidepressant activities of fluoxetine in daily chronic headache. Cephalalgia 1991;11 Suppl 11:280-1.
41. Saper 1994 {published data only} Saper JR, Silberstein SD, Lake AE 3rd, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994;34(9):497-502.
42. Sjaastad 1983 {published data only} Sjaastad O. So-called "tension headache" - the response to a 5-HT uptake inhibitor: femoxetine. Cephalalgia 1983;3(1):53-60.
43. Smith 1998 {published data only} Smith AJ. The analgesic effects of selective serotonin reuptake inhibitors. Journal of Psychopharmacology 1998;12(4):407-13.
44. Sosin 1993 {published data only} Sosin D. Clinical efficacy of fluoxetine vs sertraline in a headache clinic population. Headache 1993;33(5):284.
45. Zeeberg 1981 {published data only} Zeeberg I, Orholm M, Nielsen JD, Honoré PF, Larsen JJ. Femoxetine in the prophylaxis of migraine - a randomised comparison with placebo. Acta Neurologica Scandinavica 1981;64 (6):452-9.
46. Amelin 2000 {published data only} Amelin AV, Skoromets AA, Korenko LA, Tumelevich BCh, Gonchar MA. A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period [Sravnitel'naia effektivnost' amitriptilina, fluoksetina i maprotilina pri lechenii migreni v mezhpristupnom periode]. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 2000;100(8):20-3.
47. Voznesenskaia 1999 {published data only} Voznesenskaia TG. Prozac treatment of chronic tension headache [Lechenie prozakom khronicheskikh golovnykh bolei napriazheniia]. Zhurnal Nevrologii i Psikhiatr ii Imeni S.S. Korsakova 1999;99(1):34-6.
48. Ad Hoc 1962 Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 1962;179(9):717-8.
49. Altman 1990 Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990;335(8682):149-53.
50. Begg 1996 Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al.Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276(8):637-9.
51. Benassi 1986 Benassi G, D'Alessandro R, Lenzi PL, Manzaroli D, Baldrati A, Lugaresi E. The economic burden of headache: an epidemiological study in the Republic of San Marino. Headache 1986;26(9):457-9.
52. CC Handbook 2004 Alderson P, Green S, Higgins JPT, editors. Assessment of study quality. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Section 6. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
53. Clarke 1996 Clarke CE, MacMillan L, Sondhi S, Wells NEJ. Economic and social impact of migraine. QJM 1996;89(1):77-84.
54. Cook 1979 Cook TD, Campbell DT. Quasi-experimentation: design and analysis issues for field settings. Chicago: Rand McNally, 1979.
55. Cull 1992 Cull RE, Wells NEJ, Miochevic ML. The economic cost of migraine. British Journal of Medical Economics 1992;2:103-15.
56. Deeks 2001 Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor (s). Systematic reviews in health care: meta-analysis in context. Second Edition. London: BMJ Books, 2001:285-312.
57. Edmeads 1993 Edmeads J, Findley H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on lifestyle, consulting behaviour, and medication use: a Canadian population survey. Canadian Journal of Neurological Sciences 1993; 20(2):131-7.
58. Guaiana 2003 Guaiana G, Barbui C, Hotopf M. Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD004186]
59. Hotopf 1997 Hotopf M, Lewis G, Normand C. Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology. Journal of Epidemiology & Community Health 1997;51(4):354-8.
60. Hotopf 1999 Hotopf M, Churchill R, Lewis G. Pragmatic randomised controlled trials in psychiatry. British Journal of Psychiatry 1999;175:217-23.
61. Hu 1999 Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Archives of Internal Medicine 1999;159(8):813-8.
62. IHS 1988 Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96.
63. IHS 2004 Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:1-160.
64. Jadad 1996 Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds J, Gavaghan D, et al.Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
65. Jones 1996 Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313(7048):36-9.
66. Jüni 2001 Jüni P, Altman DG, Matthias E. Assessing the quality of randomised controlled trials. In: Egger M, Smith GD, Altman DG editor(s). Systematic reviews in health care: meta-analysis in context. 2nd Edition. London: BMJ Books, 2001:PAGE NUMBERS?.
67. Kaniecki 2003 Kaniecki R. Headache assessment and management. JAMA 2003; 289(11):1430-3.
68. Mathew 1997 Mathew NT. Transformed migraine, analgesic rebound, and other chronic daily headaches. Neurologic Clinics 1997;15(1):167-86.
69. Montgomery 1988 Montgomery SA, Dufour H, Brion S, Gailledreau J, Laqueille X, Ferrey G, et al.The prophylactic efficacy of fluoxetine in unipolar depression. British Journal of Psychiatry - Supplementum 1988, (3): 69-76.
70. Paykel 1992 Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992;305(6863): 1198-202.
71. Phillips 1998 Phillips P. Migraine as a woman's issue-will research and new treatments help?. JAMA 1998;280(23):1975-6.
72. Pocock 1997 Pocock SJ. Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation. Controlled Clinical Trials 1997;18(6):530-45.
73. Rasmussen 2001 Rasmussen BK. Epidemiology of headache. Cephalgia 2001;21(7): 774-7.
74. Robinson 1998 Robinson KA, Hinegardner PG, Lansing P. Development of an optimal search strategy for the retrieval of controlled trials using PubMed. Poster presented at 6th International Cochrane Colloquium, October 22-26, 1998, Baltimore, MD, USA. 1998.
75. Schwartz 1998 Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998;279(5):381-3.
76. Sindrup 2000 Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000;55(7):915-20.
77. Snow 2002 Snow V, Weiss K, Wall EM, Mottur-Pilson C, for the American Academy of Family Physicians and the American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Annals of Internal Medicine 2002;137(10): 840-9.
78. Thompson 2001 Thompson SG. Why and how sources of heterogeneity should be investigated. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic reviews in health care: meta-analysis in context. Second Edition. London: BMJ Books, 2001:157-75.
79. Thornley 1998 Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998;317(7167):1181-4.
80. Tomkins 2001 Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressants: a meta-analysis. American Journal of Medicine 2001;111(1):54-63.
81. Von Korff 1998 Von Korff M, Stewart WF, Simon DJ, Lipton RB. Migraine and reduced work performance: a population-based study. Neurology 1998;50(6):1741-5.
82. Wang 2003 Wang SJ. Epidemiology of migraine and other types of headaches in Asia. Current Neurology and Neuroscience Reports 2003;3(2):104-8.
83. Warlow 2001 Warlow CP. The frequency of neurological diseases. In: Donaghy M editor(s). Brain's diseases of the nervous system. 11th Edition. Oxford: Oxford University Press, 2001:9-10.